cdc2 gene expression at the G1 to S transition in human T lymphocytes

Science. 1990 Nov 9;250(4982):805-8. doi: 10.1126/science.2237430.

Abstract

The product of the cdc2 gene, designated p34cdc2, is a serine-threonine protein kinase that controls entry of eukaryotic cells into mitosis. Freshly isolated human T lymphocytes (G0 phase) were found to have very low amounts of p34cdc2 and cdc2 messenger RNA. Expression of cdc2 increased 18 to 24 hours after exposure of T cells to phytohemagglutinin, coincident with the G1 to S transition. Antisense oligodeoxynucleotides could reduce the increase in cdc2 expression and inhibited DNA synthesis, but had no effect on several early and mid-G1 events, including blastogenesis and expression of interleukin-2 receptors, transferrin receptors, c-myb, and c-myc. Induction of cdc2 required prior induction of c-myb and c-myc. These results suggest that cdc2 induction is part of an orderly sequence of events that occurs at the G1 to S transition in T cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Base Sequence
  • Blotting, Northern
  • CDC2 Protein Kinase / biosynthesis
  • CDC2 Protein Kinase / genetics*
  • Cells, Cultured
  • DNA / biosynthesis
  • DNA / genetics
  • Flow Cytometry
  • G1 Phase*
  • Gene Expression Regulation*
  • Genes, Retinoblastoma
  • Genes, myc
  • Humans
  • Lymphocyte Activation
  • Molecular Sequence Data
  • Phosphorylation
  • Polymerase Chain Reaction
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins c-myb
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • S Phase*
  • T-Lymphocytes / cytology*
  • T-Lymphocytes / metabolism

Substances

  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-myb
  • RNA, Messenger
  • DNA
  • CDC2 Protein Kinase